IASLC Lung Cancer News (ILCN), July 2023
ILCN | English
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
Table of Contents
  • Neoadjuvant Immunotherapy in NSCLC: A Window of Opportunity Not to Be Missed
  • Adjuvant IO for Operable NSCLC: Where Does It Fit a Changing Landscape?
  • Demystifying AI: How Will Artificial Intelligence Alter the Practice of Thoracic Oncology?
  • Inflammation’s Dark Symphony: Lung Cancer and Depression in Concert
  • In Brief for July 26, 2023
  • Demystifying AI: Current Insights on Artificial Intelligence in Thoracic Oncology
  • Artificial Intelligence in Healthcare: A Patient Perspective
  • Adding Pembrolizumab to Platinum and Pemetrexed Improves OS in Treatment-Naive MPM
  • Exploratory IMpower010 Analysis Shows Surgery Type Associated with Favorable DFS, OS Results
  • JTO Continues to Rank Among the Most-Cited Oncology Journals
IASLC Lung Cancer News (ILCN) is the offical news source of the only global association dedicated to the multidisciplinary study of lung cancer, published bimonthly by the International Association for the Study of Lung Cancer (IASLC). 

Click here to link to Submission Guidelines.
Powered By